Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
OvaScienceSM, (NASDAQ: OVAS), a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, today announced that the Company’s egg precursor cell (EggPCSM ) technology platform will be featured in several presentations regarding female fertility preservation at the Society for Gynecologic Investigation (SGI) Summit Jerusalem 2013. This year’s SGI Summit, “From Implantation to Parturition”, New Frontiers in Women’s Health, is being held in Israel on May 28-30, 2013.
Help employers find you! Check out all the jobs and post your resume.